Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XGNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.4.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CN.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.32 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.32 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.46.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.46.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.6 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.6 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.75.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.75.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.37 (Lambda)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.37 (Lambda)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.14 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.14 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.4 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.4 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.442NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.442NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.1 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.1 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used